Activest Wealth Management
DGX icon

Activest Wealth Management’s Quest Diagnostics DGX Stock Holding History

Activest Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4
Closed -$848 – 1135
2026
Q2 		$848 Buy
+4
New +$785 ﹤0.01% 984
2026
Q1 		– Sell
-12
Closed -$2.08K – 1259
2025
Q4 		$2.08K Hold
12
– – ﹤0.01% 883
2025
Q3 		$2.29K Buy
12
+2
+20% +$355 ﹤0.01% 766
2025
Q2 		$1.8K Sell
10
-6
-38% -$1.04K ﹤0.01% 701
2025
Q1 		$2.71K Buy
+16
New +$2.63K ﹤0.01% 610

Other funds holding DGX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Activest Wealth Management's DGX Position: Q3 2026 in Review

Activest Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 4 shares — an estimated $848 sold.

Activest Wealth Management first reported a position in DGX in Q1 2025 and held it in 5 quarters. The position peaked at $2.71K in Q1 2025. 605 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Activest Wealth Management reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Activest Wealth Management sold 4 Quest Diagnostics shares in Q3 2026, an estimated $848.
  • Activest Wealth Management first reported a position in Quest Diagnostics in Q1 2025 and held it in 5 quarters.
  • Activest Wealth Management's Quest Diagnostics position peaked at $2.71K in Q1 2025.
  • 605 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.